StockIQ.techVanda Pharmaceuticals Inc. (VNDA) Stock Analysis
Free AI-powered analysis and research for Vanda Pharmaceuticals Inc. stock
Sector: Healthcare
Full VNDA report
Vanda Pharmaceuticals Inc. (VNDA) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze VNDA Now →📰 Latest Update
Vanda Pharmaceuticals Inc (VNDA) (Q3 2026) Earnings Call Highlights: Revenue Jumps 24% as ...
Sun, November 1, 2026 at 1:02 PM UTC 4 min read
Vanda Pharmaceuticals Inc (VNDA) reported a 24% year-over-year increase in total revenue for Q3 2026, reaching $69.8 million, driven by strong sales of Fanapt and early contributions from Nereus. Despite a net loss of $22.6 million for the quarter, the company saw a significant reduction in operating expenses, down 18% from the previous quarter. Looking ahead, VNDA anticipates total revenues for the full year 2026 to exceed $240 million, with upcoming product launches expected to enhance its portfolio.